Global Molecular Diagnostics Market To Reach $7.3B By 2019
Executive Summary
The global molecular diagnostics market will grow by $2.4 billion over the next five years according to a global market report from Medtech Insight. Major factors contributing to the healthy growth of this market include advances in technology, as well as the growing understanding of the human genome, pharmacogenomics and the relationship between genes and disease/infection.
You may also be interested in...
Danaher Buys Cepheid For $4bn, Citing Molecular Diagnostics Strength
Danaher is paying a 54% premium to acquire Cepheid, maker of the fully automated GeneXpert rapid genetic testing system. Cepheid will join Danaher's $5bn Diagnostics segment, which already includes Beckman Coulter, Leica Biosystems and Radiometer. Danaher executives cited Cepheid's large installed base and potential for growth and efficiency improvements as justifications for the deal. At least one analyst believes Danaher may be paying too much.
Salus Adds Two Floradix Lines In The UK, Including Immunity Booster
Salus Haus has expanded its popular Floradix range with an immunity boosting liquid supplement and a children's verison of its flagship Floradix Liquid product.
GSK Raises Product Prices in US And Europe As Costs Rise
GSK revealed price increases in the US, Europe and China as it posted Q3 sales up high single-digits, with gains in key categories such as pain relief and vitamins, minerals and supplements.